2-aroyl-4-acyl paclitaxel (Taxol) analogs

dc.contributor.assignee	Bristol-Myers Squibb Company	en
dc.contributor.assignee	Virginia Tech Intellectual Properties, Inc.	en
dc.contributor.inventor	Kadow, John F.	en
dc.contributor.inventor	Chordia, Mahendra D.	en
dc.contributor.inventor	Jagtap, Prakash G.	en
dc.contributor.inventor	Kingston, David G. I.	en
dc.date.accessed	2016-08-19	en
dc.date.accessioned	2016-08-24T17:54:19Z	en
dc.date.available	2016-08-24T17:54:19Z	en
dc.date.filed	1998-12-30	en
dc.date.issued	2002-11-05	en
dc.description.abstract	2-debenzoyl-4-deacetyl paclitaxel, antineoplastic analogs thereof and intermediates are taught, as well as the formation of the compound, analogs and intermediates. The compound, analogs and intermediates may be used to form pharmaceutical compositions having anti-neoplastic activity. Further, the compound, analogs and intermediates may be used to treat cancer when applied in an effective amount by means such as a pharmaceutical composition.	en
dc.format.mimetype	application/pdf	en
dc.identifier.applicationnumber	9223193	en
dc.identifier.patentnumber	6476242	en
dc.identifier.uri	http://hdl.handle.net/10919/72458	en
dc.identifier.url	http://pimg-fpiw.uspto.gov/fdd/42/762/064/0.pdf	en
dc.language.iso	en_US	en
dc.publisher	United States Patent and Trademark Office	en
dc.subject.cpc	C07D493/10	en
dc.subject.cpc	C07D305/14	en
dc.subject.uspc	549/510	en
dc.subject.uspcother	549/511	en
dc.title	2-aroyl-4-acyl paclitaxel (Taxol) analogs	en
dc.type	Patent	en
dc.type.dcmitype	Text	en
dc.type.patenttype	utility	en

Files

Now showing 1 - 1 of 1